新开源(300109.SZ)及子公司呵尔医疗拟对华道生物合计增资5000万元

Core Viewpoint - The company New Open Source (300109.SZ) aims to enhance its competitive advantage in the precision medicine sector through a strategic investment in Huada Bio and its shareholders [1] Investment Details - New Open Source and its subsidiary Wuhan He'er Medical Technology Development Co., Ltd. plan to sign an investment agreement with Huada Bio and its 28 shareholders [1] - The company will invest a total of RMB 30 million and RMB 20 million in Huada Bio through capital increase, resulting in ownership stakes of 12.2150% and 0.7168% respectively [1]